Diagnosis of neurological disorders has always been pivoted on precision. But nowadays we are moving much further to Precision Neurology, with its goal to synergize continuous gains of knowledge in clinical and experimental neurosciences to utmost individualised diagnoses and treatments. Precision Neurology, thus, spans from epidemiology to genetics, body fluid biomarkers and imaging in diagnosis and prognosis of rare and common neurological disorders as well as to targeted treatments based on personalized decisions and supported by new technologies, such as artificial intelligence.
This overarching theme will be in the focus of many sessions and may engage interest of all neurologists, being clinicians or scientists, general or specialized neurologists, younger or more advanced generations.
Saturday, 19 June 2021, 08:00 – 09:30
- Transition from paediatric to adult care: Treatments for rare diseases the adult neurologist needs to know about.
- Rare neuromuscular disorders: from precise diagnosis to personalized treatment
- Rare and complex epilepsy syndromes: from precise diagnosis to personalized treatment
Sunday, 20 June 2021, 08:00 –09:30
- Genetics: What are the “true” genetic biomarkers in neurological disorders
- Body fluid markers: recent developments
- Neuroimaging: Impact on treatment decisions and disease monitoring
Monday, 21 June 2021, 10:00 – 12:00
- Epidemiology meets deep learning and artificial intelligence
- Current and future use of precise tools (e.g. genetics, biomarkers, imaging) for personalised diagnosis and prognosis
- Individual treatment decisions based on precision neurology
- Precision Medicine without limits? Ethical and economic challenges